End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
23.02 CNY | -2.99% | -1.20% | +34.54% |
Apr. 19 | Henan Lingrui Pharma Registers Chewable Asthma Drug in China | MT |
2023 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Sales 2023 * | 3.46B 477M | Sales 2024 * | 3.96B 547M | Capitalization | 12.98B 1.79B |
---|---|---|---|---|---|
Net income 2023 * | 537M 74.1M | Net income 2024 * | 641M 88.46M | EV / Sales 2023 * | 3.76 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.28 x |
P/E ratio 2023 * |
24.2
x | P/E ratio 2024 * |
20.4
x | Employees | 2,524 |
Yield 2023 * |
3.21% | Yield 2024 * |
3.82% | Free-Float | 74.14% |
1 day | -2.99% | ||
1 week | -1.20% | ||
Current month | +7.32% | ||
1 month | +9.72% | ||
3 months | +37.11% | ||
6 months | +40.54% | ||
Current year | +34.54% |
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Peng Yu
DFI | Director of Finance/CFO | 55 | - |
Jia Shu Jiang
BRD | Director/Board Member | 51 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Zhi Jun Zhao
BRD | Director/Board Member | 53 | 20-06-04 |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 06-04-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +0.68% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 23.02 | -2.99% | 10,312,180 |
24-04-23 | 23.73 | -1.00% | 8,916,497 |
24-04-22 | 23.97 | +2.09% | 7,380,619 |
24-04-19 | 23.48 | +1.73% | 6,996,412 |
24-04-18 | 23.08 | -0.94% | 7,387,557 |
End-of-day quote Shanghai S.E., April 23, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.54% | 1.79B | |
+38.08% | 6.05B | |
-16.43% | 4.45B | |
-12.46% | 3.06B | |
-0.21% | 3.04B | |
-0.59% | 2.58B | |
+0.93% | 1.66B | |
-10.63% | 1.63B | |
-12.50% | 1.54B | |
+37.15% | 1.42B |
- Stock Market
- Equities
- 600285 Stock